BiotechTube
Home/Xenothera/Odile Duvaux
OD

Odile Duvaux

Chairman, Founder & Chief Executive Officer

Xenothera

Therapeutic Areas

OncologyInfectious DiseasesImmunology

Xenothera Pipeline

DrugIndicationPhase
XON7Solid Tumors (Lung, Prostate, Ovarian, Pancreas)Phase 1/2
LIS22Peripheral T-Cell Lymphoma (PTCL)Phase 1/2
LIS1ImmunosuppressionPreclinical
XAB05/XAB06Bacterial InfectionsPreclinical
XAV19Viral InfectionsPreclinical

Leadership Team at Xenothera

FS
Françoise Shneiker
Chief Medical Officer
FB
Firas Bassissi
Chief Scientific Officer
AM
Adrien Meynard
Chief Financial Officer
CB
Céline Breda
Chief Production Officer
BV
Bernard Vanhove
Chief Strategic Officer
View full Xenothera profile